Compare · ETN vs TMO
ETN vs TMO
Side-by-side comparison of Eaton Corporation PLC (ETN) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ETN operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 1.1x ETN ($153.74B).
- Over the past year, ETN is up 21.6% and TMO is up 15.7% - ETN leads by 5.9 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 2 for ETN).
- Both have 25 recent analyst ratings on file.
- Company
- Eaton Corporation PLC
- Thermo Fisher Scientific Inc
- Price
- $395.83-5.44%
- $472.71-1.94%
- Market cap
- $153.74B
- $175.70B
- 1M return
- -6.04%
- -0.15%
- 1Y return
- +21.59%
- +15.69%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 2
- 17
- Recent ratings
- 25
- 25
Eaton Corporation PLC
Eaton Corporation plc operates as a power management company. Its Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services in North and South America, as well as hazardous duty electrical, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems internationally. The company's Hydraulics segment provides pumps, motors, and hydraulic power units; valves, cylinders, and electronic controls; industrial and hydraulic hoses, fittings, assemblies, thermoplastic hose and tubing products, couplings, connectors, and assembly equipment; and industrial drums and disc brakes. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; fuel pumps, sensors, valves, and adapters and regulators; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, cylinder heads, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. The company was founded in 1916 and is based in Dublin, Ireland.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ETN
- SEC Form SD filed by Eaton Corporation PLC
- Director Thompson Dorothy C sold $64,295 worth of Ordinary Shares (167 units at $385.00), decreasing direct ownership by 13% to 1,096 units (SEC Form 4)
- Officer Galvao Antonio sold $200,492 worth of Ordinary Shares (494 units at $405.86), decreasing direct ownership by 5% to 9,175 units (SEC Form 4)
- Director Johnson Gerald bought $390,197 worth of Ordinary Shares (961 units at $406.03), increasing direct ownership by 144% to 1,629 units (SEC Form 4)
- CORRECTION - Leverage Shares by Themes Targets Market Movers Across Tech and Industrials with Nine New 2X Single-Stock ETFs
- Leverage Shares by Themes Targets Market Movers Across Tech and Industrials with Nine New 2X Single-Stock ETFs
- Director Page Gregory R converted options into 621 units of Ordinary Shares and covered exercise/tax liability with 150 units of Ordinary Shares, increasing direct ownership by 1% to 44,090 units (SEC Form 4)
- Director Napoli Silvio converted options into 621 units of Ordinary Shares and covered exercise/tax liability with 299 units of Ordinary Shares, increasing direct ownership by 22% to 1,756 units (SEC Form 4)
- Officer Monesmith Heath B. sold $7,514,074 worth of Ordinary Shares (18,367 units at $409.11), decreasing direct ownership by 27% to 49,822 units (SEC Form 4)
- Director Johnson Gerald converted options into 353 units of Ordinary Shares and covered exercise/tax liability with 85 units of Ordinary Shares, increasing direct ownership by 67% to 668 units (SEC Form 4)
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)